Atai: Following the path that Spravato laid and moving beyond it
Investing Experts
Exploring Milestones in the BPL-03 Clinical Trial
This chapter outlines the key milestones in the phase 2b clinical trial for BPL-03, an intranasal formulation of 5-methoxy DMT. It highlights the trial structure, patient randomization, and the focus on measuring the treatment's efficacy and durability in addressing depression.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
